ADA outlines associated risks with use of oral bisphosphonate.
Those who are on oral bisphosphonates, a treatment measure for patients suffering osteoporosis, osteopenia and Paget's disease of bone, should be told about the potential risks// during certain Paget's disease , according to guidelines published in this month's Journal of the American Dental Association (ADA). Relying on a small but growing number of reports linking bisphosphonate dr...Drugs With Bisphosphonates Packs Osteonecrosis Risk
A report on the Journal of General Dentistry reveals breast cancer patients, people with osteoporosis, and individuals undergoing bone cancer therapies are supposed //to take drugs that contain bisphosphonates, which puts patients at risk of developing osteonecrosis of the jaws (a rotting of the jaw bones). Bisphosphonates are a family of drugs used to prevent and treat osteoporosis, mu...Bisphosphonates to Treat Multiple Myeloma
Regarding the use of bisphosphonates in treatment or prevention of bone diseases in Multiple Myeloma (MM), a consensus report has been issued by the Mayo Clinic's// multiple myeloma (MM) research team. This report deals with several controversial issues, like the type of bisphosphonate to be used and the duration of such therapy. This is published in the August issue of Mayo Clinic Proceedings. <...Bisphosphonate Increases the Risk of Jaw Bone Deterioration
Patients treated with intravenous bisphosphonates are at an increased risk of jaw or facial bone deterioration or infection. Bisphosphonates are used to treat cancer-related bone lesions, elevated levels of calcium in the blood, or reduced bone density. Several recent studies have found an association between the use of intravenous bisphosphonates and osteonecrosis of the jaw or fa...